Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

13.42
Delayed Data
As of Apr 24
 -0.25 / -1.83%
Today’s Change
4.13
Today|||52-Week Range
13.77
+18.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues34.2M48.9M47.8M102.8M
 
 
 
 
 
Depreciation And Amortization5.3M3.7M2.6M3.2M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses109.8M138.0M164.9M165.8M
 
 
 
 
 
Research And Development100.6M125.9M146.3M138.5M
 
 
 
 
 
Total Operating Expenses115.1M141.7M167.5M169.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-80.9M-92.7M-119.7M-66.3M
 
 
 
 
 
Extraordinary Charge-864.0K0.00-800.0K0.00
 
 
 
Interest Expense On Debt13.0K553.0K10.9M18.2M
 
 
 
 
 
Other Expenses2.0M1.4M627.0K813.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-79.7M-91.8M-130.7M-83.6M
 
 
 
 
 
Minority Interest-453.0K-477.0K-240.0K-268.0K
 
 
 
 
 
Net Income-79.2M-91.3M-130.9M-83.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.3M72.8M98.9M104.4M
 
 
 
 
 
Shares To Calculate EPS Diluted11.3M72.8M98.9M104.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$7.67-$1.28-$1.32-$0.80
 
 
 
 
 
EPS Diluted-$6.98-$1.25-$1.32-$0.80
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account